Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression

Si-Jian Pan1, Yue-Bing Wu2, Shang Cai3

  • 1Department of Neurosurgery, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.

Insights

Tetraspanin 8 (Tspn8) promotes malignant glioma growth and resistance to temozolomide (TMZ). Targeting Tspn8 may offer a new therapeutic strategy for glioblastoma by inhibiting proliferation and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Malignant glioma is a deadly cancer where tumor cell invasion and proliferation are primary causes of death.
  • Identifying novel therapeutic targets is crucial for developing effective treatments for malignant glioma.
  • Tetraspanin 8 (Tspn8) is a transmembrane protein involved in regulating cellular functions.

Purpose of the Study:

  • To investigate the role of Tetraspanin 8 (Tspn8) in malignant glioma.
  • To determine if Tspn8 expression correlates with tumor grade and affects glioma cell proliferation, migration, and response to temozolomide (TMZ).
  • To explore the interaction between Tspn8 and focal adhesion kinase (FAK) in glioma.

Main Methods:

  • Analysis of Tspn8 expression in clinical malignant glioma tissues and cell lines (U251MG, U87MG).
  • siRNA-mediated knockdown of Tspn8 to assess its impact on cell proliferation, migration, and apoptosis.
  • Investigation of the Tspn8-FAK complex formation and its effect on FAK activation.
  • Assessment of Tspn8 knockdown's influence on temozolomide (TMZ) sensitivity.

Main Results:

  • Tspn8 was over-expressed in malignant glioma tissues, with expression levels correlating with tumor grade.
  • Tspn8 knockdown significantly reduced proliferation and migration of U251MG and U87MG cells.
  • Silencing Tspn8 enhanced sensitivity to temozolomide (TMZ), leading to increased cell death and apoptosis.
  • Tspn8 formed a complex with activated focal adhesion kinase (FAK), and Tspn8 knockdown inhibited FAK activation.

Conclusions:

  • Tspn8 promotes glioblastoma pathogenesis by enhancing proliferation, migration, and temozolomide (TMZ) resistance.
  • Tspn8's role in FAK activation is critical for its function in glioma cells.
  • Targeting Tspn8 presents a potential therapeutic strategy for malignant glioma.